What is Palvella Therapeutics's shares (basic)?

Palvella Therapeutics (PVLA) reported shares (basic) of 13.1M in Q1 2026.

How has Palvella Therapeutics's shares (basic) changed year-over-year?

Palvella Therapeutics's shares (basic) increased by 18.8% year-over-year, from 11M to 13.1M.

What is the long-term trend for Palvella Therapeutics's shares (basic)?

Over 2 years (2021 to 2025), Palvella Therapeutics's shares (basic) has grown at a -57.9% compound annual growth rate (CAGR), from 250.5M to 44.4M.

What does shares (basic) mean?

The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.

Palvella Therapeutics PVLA Shares (Basic)

Shares (Basic) at other companies

Relay Therapeutics, Inc.RLAY

179.8M+6.3%

Viridian Therapeutics, Inc.VRDN

66.4M+52.1%

ANI PharmaceuticalsANIP

20.9M+6.7%

PrecigenPGEN

354.3M+20.6%

Arcutis Biotherapeutics, Inc.ARQT

129.4M+2.6%

Kodiak Sciences IncKOD

61.9M+17.3%

Other financials

Income statement

See full

Revenue$53.0K-97.3%

Operating income-$14.9M-88.7%

Net income-$15.8M-92.6%

EPS (diluted)-$1.20-62.2%

Balance sheet

See full

Cash & equivalents$206.4M+173%

Total debt$584.0K—

Total equity$232.3M+318%

Total assets$263.8M+232%

Cash flow

See full

Operating cash flow-$10.9M-60.5%

CapEx--100%

Free cash flow-$2.7M+72.0%

Valuation

See full

Market cap$1.7B+468%

Enterprise value$1.5B—

P/S41.6×—

Profitability

See full

Operating margin-183.2%-13.5pp

Net margin71.7%+40.4pp

FCF margin-99.8%-34.2pp

Returns & leverage

See full

Return on equity-34.2%—

Debt / equity0×—

Current ratio28.9×+20.0×

Where this comes from

Reported directly by Palvella Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Palvella Therapeutics's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Palvella Therapeutics's shares (basic)?: Palvella Therapeutics (PVLA) reported shares (basic) of 13.1M in Q1 2026.
How has Palvella Therapeutics's shares (basic) changed year-over-year?: Palvella Therapeutics's shares (basic) increased by 18.8% year-over-year, from 11M to 13.1M.
What is the long-term trend for Palvella Therapeutics's shares (basic)?: Over 2 years (2021 to 2025), Palvella Therapeutics's shares (basic) has grown at a -57.9% compound annual growth rate (CAGR), from 250.5M to 44.4M.
What does shares (basic) mean?: The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.